Drug Profile
Diclofenac sodium - Transdermal Delivery Solutions
Alternative Names: Diclofenac sodium spray - Transdermal Delivery Solutions; Disclofenac sodium TDS®Latest Information Update: 24 Aug 2023
Price :
$50
*
At a glance
- Originator Transdermal Delivery Solutions Corp
- Developer St. Bartholomews Hospital; Transdermal Delivery Solutions Corp
- Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 24 Aug 2023 Discontinued - Preclinical for Pain in USA (Transdermal)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Pain in USA (Transdermal, Spray)
- 27 May 2016 Diclofenac transdermal is still in non-clinical development for Pain (Company website - May 2016)